Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

A deep learning model was as effective as radiologists in detecting clinically significant prostate cancer on multiparametric MRI, a retrospective study suggested. In an internal test set of 400 ...

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

The MRI-based prostate biopsy risk stratification tools with the greatest accuracy were the RPCRC-MRI and PLUM models Among MRI-based risk calculators for prostate biopsy, 2 models provide more ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...